ZD6474 in Treating Patients With Small Cell Lung Cancer

The requested reference [980d2739e53262633466feb1181313ef6c55a560] no longer exists in our database. It has been replaced by the current reference: [1f315af592e7ec163c5627740b7f00b248e9c8c0]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
RATIONALE: ZD6474 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. ZD6474 may also stop the growth of small cell lung cancer by blocking blood flow to the tumor. PURPOSE: This randomized phase II trial is studying how well ZD6474 works compared to placebo in treating patients with small cell lung cancer that has responded to previous chemotherapy with or without radiation therapy.
Epistemonikos ID: 390a9541e6695454d1a14457372b5330977a4224
First added on: May 04, 2024